Effectively Implementing PAT & Quality by Design

January 24, 2007

Effectively Implementing PAT & Quality by Design

28 - 29 March, 2007 - Swissotel the Howard, London, UK

www.iqpc-pharma.com/uk/pat/pt

The pharmaceutical industry is now investing heavily in PAT and working towards full implementation and quality by design. However, there are still numerous technical and organisational difficulties in applying these tools and strategies.

Pharma IQ's 4th annual PAT conference will take a practical look at HOW to implement PAT, not WHY. With a case study focussed programme, the meeting will provide detailed examples of real successes and failures of PAT applications. It will demonstrate how attendees can improve their process understanding and control and how this will lead them to the promised benefits of PAT.

Key programme highlights include:

  • Yatindra Joshi, Novartis discusses process monitoring and control to ensure a full approach to quality by design
  • Tom Cochrane, Napp Pharmaceuticals reveals how they are developing a holistic approach to process understanding
  • Steven Flatman, Lonza Biologics looks at how PAT & QbD can be applied in biotech processes
  • Edwin Kellenbach, Organon examines how QbD should be implemented in API manufacturing
  • Amy McDaniel, Wyeth Biopharma explores the application of PAT to improve rapid microbiological methods
  • Keith Pugh, MHRA gives a regulatory update on PAT & QbD from the EMEA team

Come together with industry, regulators and technology providers. Join us at this leading European forum to discuss effective strategies to implement PAT and risk based models to improve efficiency in development through to manufacturing.

For more details and to register please visit www.iqpc-pharma.com/uk/pat/pt